Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibroblast growth factor-2.

M Okada-Ban1, J P Thiery, J Jouanneau

  • 1Institut Curie, UMR 144/CNRS, Laboratory of Morphogenesis and Tumor Progression, Paris, France.

The International Journal of Biochemistry & Cell Biology
|March 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture?

Transfusion medicine (Oxford, England)·2017
Same author

Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells.

Scientific reports·2017
Same author

An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.

Cell death discovery·2016
Same author

FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.

Cell death & disease·2014
Same author

Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

Oncogene·2014
Same author

Actin dynamics modulate mechanosensitive immobilization of E-cadherin at adherens junctions.

Nature cell biology·2014
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Fibroblast growth factor-2 (FGF-2) is a key protein with multiple roles in cell development and tissue repair. While not essential for embryonic development, FGF-2 shows therapeutic promise for cardiovascular diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • Fibroblast growth factor-2 (FGF-2) is a heparin-binding growth factor with multiple isoforms.
  • It plays critical roles in cell migration, differentiation, and development.
  • FGF-2 can be secreted and acts through paracrine/autocrine and intracrine mechanisms.

Purpose of the Study:

  • To investigate the biological functions and therapeutic potential of Fibroblast growth factor-2 (FGF-2).
  • To understand the role of FGF-2 in embryonic development and neuronal differentiation.
  • To explore the application of FGF-2 in treating ischemic cardiovascular diseases.

Main Methods:

  • Analysis of FGF-2 isoforms generated by alternative translation initiation.
  • Investigation of FGF-2 secretion and signaling pathways (paracrine/autocrine and intracrine).

Related Experiment Videos

  • Evaluation of FGF-2 function in knock-out mouse models, focusing on embryonic development and neuronal differentiation.

    • Main Results:

    • FGF-2 exists in cytoplasmic and nuclear isoforms with distinct molecular weights.
    • FGF-2 knock-out mice are viable but show abnormalities in neuronal differentiation.
    • FGF-2 demonstrates potential as a therapeutic agent for ischemic cardiovascular disease, with ongoing clinical trials.

    Conclusions:

    • FGF-2 has diverse biological functions, potentially isoform-specific.
    • FGF-2 is not essential for embryonic development but influences neuronal differentiation.
    • FGF-2 holds promise for therapeutic applications in cardiovascular disease treatment.